Albania - Age dependency ratio, young (% of working-age population)

Age dependency ratio, young (% of working-age population) in Albania was reported at 26.86 % in 2015, according to the World Bank collection of development indicators, compiled from officially recognized sources.



albania age dependency ratio young percent of working age population wb data




We will not not share your email with third parties and you can unsubscribe at any time.
Please Paste this Code in your Website
width
height
 Preview


Age dependency ratio, young, is the ratio of younger dependents--people younger than 15--to the working-age population--those ages 15-64. Data are shown as the proportion of dependents per 100 working-age population.


Albania | Health

Women who believe a husband is justified in beating his wife when she argues with him
12.1 %
Women who believe a husband is justified in beating his wife when she burns the food
4.4 %
Women who believe a husband is justified in beating his wife when she goes out without telling him
18.6 %
Women who believe a husband is justified in beating his wife when she neglects the children
21.7 %
Women who believe a husband is justified in beating his wife (any of five reasons)
29.8 %
Women who believe a husband is justified in beating his wife when she refuses sex with him
8.9 %
Problems in accessing health care (not wanting to go alone) (% of women): Q1 (lowest)
64 %
Problems in accessing health care (not wanting to go alone) (% of women): Q2
52 %
Problems in accessing health care (not wanting to go alone) (% of women): Q3
37.1 %
Problems in accessing health care (not wanting to go alone) (% of women): Q4
27.4 %
Problems in accessing health care (not wanting to go alone) (% of women): Q5 (highest)
15.8 %
Problems in accessing health care (distance to health facility) (% of women): Q1 (lowest)
61.1 %
Problems in accessing health care (distance to health facility) (% of women): Q2
43.6 %
Problems in accessing health care (distance to health facility) (% of women): Q3
27.8 %
Problems in accessing health care (distance to health facility) (% of women): Q4
12.6 %
Problems in accessing health care (distance to health facility) (% of women): Q5 (highest)
5.6 %
Problems in accessing health care (getting money for treatment) (% of women): Q1 (lowest)
80.2 %
Problems in accessing health care (getting money for treatment) (% of women): Q2
62.8 %
Problems in accessing health care (getting money for treatment) (% of women): Q3
57.7 %
Problems in accessing health care (getting money for treatment) (% of women): Q4
55.3 %
Problems in accessing health care (getting money for treatment) (% of women): Q5 (highest)
26.5 %
Problems in accessing health care (concern there may not be a female provider) (% of women): Q1 (lowest)
33.7 %
Problems in accessing health care (concern there may not be a female provider) (% of women): Q2
22.3 %
Problems in accessing health care (concern there may not be a female provider) (% of women): Q3
18.2 %
Problems in accessing health care (concern there may not be a female provider) (% of women): Q4
12.9 %
Problems in accessing health care (concern there may not be a female provider) (% of women): Q5 (highest)
10.1 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q1 (lowest)
33.2 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q2
21.2 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q3
16.8 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q4
8.2 %
Problems in accessing health care (getting permission to go for treatment) (% of women): Q5 (highest)
4.4 %
Problems in accessing health care (any of the specified problems) (% of women): Q1 (lowest)
94.8 %
Problems in accessing health care (any of the specified problems) (% of women): Q2
86.5 %
Problems in accessing health care (any of the specified problems) (% of women): Q3
75.5 %
Problems in accessing health care (any of the specified problems) (% of women): Q4
70.5 %
Problems in accessing health care (any of the specified problems) (% of women): Q5 (highest)
41 %
Problems in accessing health care (having to take transport) (% of women): Q1 (lowest)
64 %
Problems in accessing health care (having to take transport) (% of women): Q2
43.2 %
Problems in accessing health care (having to take transport) (% of women): Q3
31.4 %
Problems in accessing health care (having to take transport) (% of women): Q4
17.9 %
Problems in accessing health care (having to take transport) (% of women): Q5 (highest)
5.8 %
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
6.6
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
21.5 %
Prevalence of anemia among children (% of children under 5)
22.4 %
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
21.5 %
Condom use; population ages 15-24; female (% of females ages 15-24)
12.6 %
Condom use; population ages 15-24; male (% of males ages 15-24)
49.8 %
Condom use with non regular partner, % adults(15-49), female
24.9 %
Condom use with non regular partner, % adults(15-49), male
51.4 %
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
3.5 %
Number of infant deaths
564
Cause of death, by injury (% of total)
4 %
Number of under-five deaths
618
Cause of death, by non-communicable diseases (% of total)
92.4 %
Number of neonatal deaths
279
Female adults with HIV (% of population ages 15+ with HIV)
29.1 %
Prevalence of HIV, total (% of population ages 15-49)
0.1 %
Mortality rate, female child (per 1,000 female children age one)
1
Mortality rate, under-5 (per 1,000)
14
Mortality rate, under-5, female (per 1,000 live births)
12.5
Mortality rate, under-5, male (per 1,000 live births)
15.3
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
34.4
Under-5 mortality rate (per 1,000 live births): Q2
13.1
Under-5 mortality rate (per 1,000 live births): Q3
24.4
Under-5 mortality rate (per 1,000 live births): Q4
20.4
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
13.2
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
15 %
Mortality rate; neonatal (per 1;000 live births)
6.2
Median age at first birth (women ages 25-49): Q1 (lowest)
23.1
Median age at first birth (women ages 25-49): Q2
22.6
Median age at first birth (women ages 25-49): Q3
22.9
Median age at first birth (women ages 25-49): Q4
23.5
Median age at first birth (women ages 25-49): Q5 (highest)
24.7
Median age at first marriage (women ages 25-49): Q1 (lowest)
21.5
Median age at first marriage (women ages 25-49): Q2
21
Median age at first marriage (women ages 25-49): Q3
21.3
Median age at first marriage (women ages 25-49): Q4
22.1
Median age at first marriage (women ages 25-49): Q5 (highest)
23.1
Median age at first sexual intercourse (women ages 25-49): Q1 (lowest)
21
Median age at first sexual intercourse (women ages 25-49): Q2
20.7
Median age at first sexual intercourse (women ages 25-49): Q3
20.7
Median age at first sexual intercourse (women ages 25-49): Q4
21.1
Median age at first sexual intercourse (women ages 25-49): Q5 (highest)
21.2
Heard family planning on radio and television (% of women): Q1 (lowest)
3.3 %
Heard family planning on radio and television (% of women): Q2
7.5 %
Heard family planning on radio and television (% of women): Q3
9.8 %
Heard family planning on radio and television (% of women): Q4
11.7 %
Heard family planning on radio and television (% of women): Q5 (highest)
20.5 %
Mean ideal number of children (per woman): Q1 (lowest)
2.7
Mean ideal number of children (per woman): Q2
2.7
Mean ideal number of children (per woman): Q3
2.6
Mean ideal number of children (per woman): Q4
2.4
Mean ideal number of children (per woman): Q5 (highest)
2.3
Knowledge of contraception (any method) (% of married women): Q1 (lowest)
99.1 %
Knowledge of contraception (any method) (% of married women): Q2
99.2 %
Knowledge of contraception (any method) (% of married women): Q3
99.5 %
Knowledge of contraception (any method) (% of married women): Q4
99.7 %
Knowledge of contraception (any method) (% of married women): Q5 (highest)
100 %
Knowledge of contraception (modern method) (% of married women): Q1 (lowest)
90 %
Knowledge of contraception (modern method) (% of married women): Q2
92.4 %
Knowledge of contraception (modern method) (% of married women): Q3
94.7 %
Knowledge of contraception (modern method) (% of married women): Q4
95.7 %
Knowledge of contraception (modern method) (% of married women): Q5 (highest)
99.4 %
Desire to stop (limit) childbearing (% of married women): Q1 (lowest)
72 %
Desire to stop (limit) childbearing (% of married women): Q2
75.6 %
Desire to stop (limit) childbearing (% of married women): Q3
74.1 %
Desire to stop (limit) childbearing (% of married women): Q4
73.2 %
Desire to stop (limit) childbearing (% of married women): Q5 (highest)
68.6 %
Median birth interval (months): Q1 (lowest)
46
Median birth interval (months): Q2
47
Median birth interval (months): Q3
44
Median birth interval (months): Q4
49
Median birth interval (months): Q5 (highest)
54
Fertility planning status (wanted later) (% of births): Q1 (lowest)
9 %
Fertility planning status (wanted later) (% of births): Q2
11.3 %
Fertility planning status (wanted later) (% of births): Q3
8.2 %
Fertility planning status (wanted later) (% of births): Q4
7.3 %
Fertility planning status (wanted later) (% of births): Q5 (highest)
7.1 %
Family planning messages in print (% of women): Q1 (lowest)
7.6 %
Family planning messages in print (% of women): Q2
15.5 %
Family planning messages in print (% of women): Q3
23.3 %
Family planning messages in print (% of women): Q4
29.1 %
Family planning messages in print (% of women): Q5 (highest)
45 %
Demand for family planning satisfied by modern methods (% of married women with demand for family planning)
12.9 %
Fertility planning status (wanted no more) (% of births): Q1 (lowest)
6.5 %
Fertility planning status (wanted no more) (% of births): Q2
4.3 %
Fertility planning status (wanted no more) (% of births): Q3
4.8 %
Fertility planning status (wanted no more) (% of births): Q4
2.1 %
Fertility planning status (wanted no more) (% of births): Q5 (highest)
0.7 %
Fertility planning status (wanted then) (% of births): Q1 (lowest)
84.5 %
Fertility planning status (wanted then) (% of births): Q2
84.3 %
Fertility planning status (wanted then) (% of births): Q3
87 %
Fertility planning status (wanted then) (% of births): Q4
90.6 %
Fertility planning status (wanted then) (% of births): Q5 (highest)
92.2 %
Prevalence of HIV, female (% ages 15-24)
0.1 %
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
35.9
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)
22
Prevalence of HIV, male (% ages 15-24)
0.1 %
Antiretroviral therapy coverage (% of people with advanced HIV infection)
52 %
% of females ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
28.4 %
% of males ages 15-49 having comprehensive correct knowledge about HIV (2 prevent ways and reject 3 misconceptions)
20.3 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
100 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
94.4 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
91.1 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
94.3 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
96.9 %
Immunization, Hib3 (% of children ages 12-23 months)
98 %
Immunization, BCG (% of one-year-old children)
99 %
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
100 %
Vaccinations (BCG) (% of children ages 12-23 months): Q2
100 %
Vaccinations (BCG) (% of children ages 12-23 months): Q3
95.7 %
Vaccinations (BCG) (% of children ages 12-23 months): Q4
94.3 %
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
100 %
Immunization, DPT (% of children ages 12-23 months)
98 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
100 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
97.5 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
98.2 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
94.3 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
96.9 %
Immunization, measles (% of children ages 12-23 months)
98 %
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
100 %
Vaccinations (Measles) (% of children ages 12-23 months): Q2
96.9 %
Vaccinations (Measles) (% of children ages 12-23 months): Q3
93.6 %
Vaccinations (Measles) (% of children ages 12-23 months): Q4
94.3 %
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
100 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
1.8 %
Immunization, Pol3 (% of one-year-old children)
98 %
Hospital beds
2.6
Nurses and midwives
3.85
Physicians
1.14
Specialist surgical workforce (per 100,000 population)
11.63
Number of maternal mortality deaths
11
Lifetime risk of maternal death (1 in: rate varies by country)
1900
Lifetime risk of maternal death
0.0534 %
Prevalence of anemia among pregnant women
21.6 %
Smoking prevalence, females (% of adults)
7.6 %
Smoking (% of women): Q1 (lowest)
0.8 %
Smoking (% of women): Q2
1.1 %
Smoking (% of women): Q3
2.1 %
Smoking (% of women): Q4
5 %
Smoking (% of women): Q5 (highest)
11.5 %
Smoking prevalence, males (% of adults)
51.2 %
Risk of catastrophic expenditure for surgical care (% of people at risk)
26.5 %
Risk of impoverishing expenditure for surgical care (% of people at risk)
11.3 %
Number of surgical procedures (per 100,000 population)
1900
Improved sanitation facilities (% of population with access)
93.2 %
Improved sanitation facilities, urban (% of urban population with access)
95.5 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q1 (lowest)
23.9 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q2
26.5 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q3
40 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q4
49.9 %
Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q5 (highest)
62.7 %
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
66.8 %
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
96.4 %
Antenatal care (any skilled personnel) (% of women with a birth): Q2
96.8 %
Antenatal care (any skilled personnel) (% of women with a birth): Q3
98.8 %
Antenatal care (any skilled personnel) (% of women with a birth): Q4
99.9 %
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
98.8 %
Pregnant women receiving prenatal care
97.3 %
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
65 %
Antenatal care (doctor) (% of women with a birth): Q2
73.2 %
Antenatal care (doctor) (% of women with a birth): Q3
82.4 %
Antenatal care (doctor) (% of women with a birth): Q4
91.4 %
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
95.5 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
51.7 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
65 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
86 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
93.3 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
48.8 %
ARI treatment (% of children under 5 taken to a health provider)
69.6 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
7.5 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
4.8 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
8.2 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
2.8 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
2.4 %
Breastfeeding (% of children under 6 months): Q1 (lowest)
95.4 %
Breastfeeding (% of children under 6 months): Q2
89.8 %
Breastfeeding (% of children under 6 months): Q3
96.6 %
Breastfeeding (% of children under 6 months): Q4
84.6 %
Breastfeeding (% of children under 6 months): Q5 (highest)
89 %
Exclusive breastfeeding (% of children under 6 months)
38.6 %
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
99.5 %
Assistance during delivery (any skilled personnel) (% of births): Q2
99.3 %
Assistance during delivery (any skilled personnel) (% of births): Q3
98.9 %
Assistance during delivery (any skilled personnel) (% of births): Q4
100 %
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
100 %
Births attended by skilled health staff (% of total)
99.3 %
Place of delivery (births at health facility) (% of births): Q1 (lowest)
94.3 %
Place of delivery (births at health facility) (% of births): Q2
98.3 %
Place of delivery (births at health facility) (% of births): Q3
98.9 %
Place of delivery (births at health facility) (% of births): Q4
99 %
Place of delivery (births at health facility) (% of births): Q5 (highest)
99.6 %
Assistance during delivery (doctor) (% of births): Q1 (lowest)
71.9 %
Assistance during delivery (doctor) (% of births): Q2
78.1 %
Assistance during delivery (doctor) (% of births): Q3
84.7 %
Assistance during delivery (doctor) (% of births): Q4
95.7 %
Assistance during delivery (doctor) (% of births): Q5 (highest)
94.9 %
Low-birthweight babies (% of births)
3.6 %
Diabetes prevalence (% of population ages 20 to 79)
10.3 %
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
5.5 %
Prevalence of diarrhea (% of children under 5): Q2
5.9 %
Prevalence of diarrhea (% of children under 5): Q3
7.1 %
Prevalence of diarrhea (% of children under 5): Q4
3.3 %
Prevalence of diarrhea (% of children under 5): Q5 (highest)
4.2 %
Infant and young child feeding practices, all 3 IYCF (% children ages 6-23 months)
18.7 %
Malnourished women (BMI is less than 18.5) (% of women): Q1 (lowest)
2.5 %
Malnourished women (BMI is less than 18.5) (% of women): Q2
2.3 %
Malnourished women (BMI is less than 18.5) (% of women): Q3
4.4 %
Malnourished women (BMI is less than 18.5) (% of women): Q4
2.2 %
Malnourished women (BMI is less than 18.5) (% of women): Q5 (highest)
4.4 %
Prevalence of underweight, weight for age, female (% of children under 5)
6 %
Prevalence of underweight, weight for age, male (% of children under 5)
6.6 %
Malnourished children (underweight, -2SD) (% of children under 5): Q1 (lowest)
7.9 %
Malnourished children (underweight, -2SD) (% of children under 5): Q2
3.5 %
Malnourished children (underweight, -2SD) (% of children under 5): Q3
5.9 %
Malnourished children (underweight, -2SD) (% of children under 5): Q4
4.7 %
Malnourished children (underweight, -2SD) (% of children under 5): Q5 (highest)
3.6 %
Malnutrition prevalence, weight for age (% of children under 5)
6.3 %
Malnourished children (underweight, -3SD) (% of children under 5): Q1 (lowest)
2 %
Malnourished children (underweight, -3SD) (% of children under 5): Q2
1.9 %
Malnourished children (underweight, -3SD) (% of children under 5): Q3
1.2 %
Malnourished children (underweight, -3SD) (% of children under 5): Q4
1.4 %
Malnourished children (underweight, -3SD) (% of children under 5): Q5 (highest)
1.8 %
Maternal mortality ratio (modeled estimate, per 100,000 live births)
29
Maternal mortality ratio (national estimate; per 100;000 live births)
5.8
People practicing open defecation, rural (% of rural population)
0 %
People practicing open defecation, urban (% of urban population)
0 %
People practicing open defecation (% of population)
0 %
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
63.3 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q1 (lowest)
55.4 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q2
89 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q3
86.6 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q4
51.3 %
Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q5 (highest)
79.3 %
Knowledge of diarrhea care (% of mothers): Q1 (lowest)
72.8 %
Knowledge of diarrhea care (% of mothers): Q2
68 %
Knowledge of diarrhea care (% of mothers): Q3
83.1 %
Knowledge of diarrhea care (% of mothers): Q4
84.2 %
Knowledge of diarrhea care (% of mothers): Q5 (highest)
92.2 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q1 (lowest)
45.8 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q2
79.7 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q3
78.8 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q4
46.9 %
Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q5 (highest)
79.3 %
Diarrhea treatment (% of children under 5 who received ORS packet)
54.3 %
Prevalence of overweight, female (% of female adults)
45.4 %
Prevalence of overweight, male (% of male adults)
58.4 %
Prevalence of overweight, weight for height, female (% of children under 5)
23.4 %
Prevalence of overweight, weight for height, male (% of children under 5)
23.3 %
Prevalence of overweight (% of children under 5)
23.4 %
Postnatal care coverage (% mothers)
85.1 %
Malnourished children (stunting, -3SD) (% of children under 5): Q1 (lowest)
15.8 %
Malnourished children (stunting, -3SD) (% of children under 5): Q2
9.2 %
Malnourished children (stunting, -3SD) (% of children under 5): Q3
8.9 %
Malnourished children (stunting, -3SD) (% of children under 5): Q4
10 %
Malnourished children (stunting, -3SD) (% of children under 5): Q5 (highest)
8.6 %
Prevalence of stunting, height for age, female (% of children under 5)
23.4 %
Prevalence of stunting, height for age, male (% of children under 5)
22.8 %
Malnourished children (stunting, -2SD) (% of children under 5): Q1 (lowest)
27 %
Malnourished children (stunting, -2SD) (% of children under 5): Q2
15.4 %
Malnourished children (stunting, -2SD) (% of children under 5): Q3
18.9 %
Malnourished children (stunting, -2SD) (% of children under 5): Q4
20.6 %
Malnourished children (stunting, -2SD) (% of children under 5): Q5 (highest)
13.3 %
Malnutrition prevalence, height for age (% of children under 5)
23.1 %
Suicide mortality rate (per 100,000 population)
4.3
Mortality caused by road traffic injury (per 100,000 people)
13.6
Prevalence of wasting, weight for height, female (% of children under 5)
7.3 %
Prevalence of wasting, weight for height, male (% of children under 5)
11.5 %
Malnourished children (wasting, -2SD) (% of children under 5): Q1 (lowest)
6.4 %
Malnourished children (wasting, -2SD) (% of children under 5): Q2
11.7 %
Malnourished children (wasting, -2SD) (% of children under 5): Q3
9.3 %
Malnourished children (wasting, -2SD) (% of children under 5): Q4
6.9 %
Malnourished children (wasting, -2SD) (% of children under 5): Q5 (highest)
11.9 %
Prevalence of wasting (% of children under 5)
9.4 %
Malnourished children (wasting, -3SD) (% of children under 5): Q1 (lowest)
3.7 %
Malnourished children (wasting, -3SD) (% of children under 5): Q2
6.3 %
Malnourished children (wasting, -3SD) (% of children under 5): Q3
5.5 %
Malnourished children (wasting, -3SD) (% of children under 5): Q4
4.6 %
Malnourished children (wasting, -3SD) (% of children under 5): Q5 (highest)
7.7 %
Prevalence of severe wasting, weight for height, female (% of children under 5)
4.3 %
Prevalence of severe wasting, weight for height, male (% of children under 5)
7.5 %
Prevalence of severe wasting, weight for height (% of children under 5)
5.9 %
Tuberculosis treatment success rate (% of registered cases)
88 %
Tuberculosis case detection rate (all forms)
76 %
Incidence of tuberculosis (per 100,000 people)
19
Tuberculosis death rate (per 100,000 people)
0.35
Newborns protected against tetanus
92 %
Outpatient visits per capita
1.48
External resources for health (% of total expenditure on health)
0.6219 %
Out-of-pocket health expenditure (% of total expenditure on health)
49.93 %
Out-of-pocket health expenditure (% of private expenditure on health)
99.69 %
Health expenditure per capita
272 USD
Health expenditure per capita, PPP (constant 2005 international $)
615
Health expenditure, private (% of GDP)
2.95 %
Health expenditure, public (% of total health expenditure)
49.91 %
Health expenditure, public (% of government expenditure)
9.37 %
Health expenditure, public (% of GDP)
2.94 %
Health expenditure, total (% of GDP)
5.88 %
Refugee population by country or territory of asylum
104
Refugee population by country or territory of origin
10421
Prevalence of undernourishment (% of population)
5 %
Depth of hunger (kilocalories per person per day)
160
Consumption of iodized salt (% of households)
75.1 %
Vitamin A supplements for postpartum women (% of women with a birth): Q1 (lowest)
17.7 %
Vitamin A supplements for postpartum women (% of women with a birth): Q2
13.5 %
Vitamin A supplements for postpartum women (% of women with a birth): Q3
32.3 %
Vitamin A supplements for postpartum women (% of women with a birth): Q4
31.9 %
Vitamin A supplements for postpartum women (% of women with a birth): Q5 (highest)
38.3 %
Vitamin A supplements for children (% of children ages 6-59 months): Q1 (lowest)
4.9 %
Vitamin A supplements for children (% of children ages 6-59 months): Q2
8.4 %
Vitamin A supplements for children (% of children ages 6-59 months): Q3
9.7 %
Vitamin A supplements for children (% of children ages 6-59 months): Q4
7.2 %
Vitamin A supplements for children (% of children ages 6-59 months): Q5 (highest)
11.1 %
Adolescent fertility rate (births per 1,000 women ages 15-19)
21.84
Completeness of infant death reporting (% of reported infant deaths to estimated infant deaths)
29.56 %
Completeness of total death reporting (% of reported total deaths to estimated total deaths)
84.87 %
Mortality rate, adult, female (per 1,000 female adults)
49.69
Mortality rate, adult, male (per 1,000 male adults)
83.57
Birth rate, crude
13.63
Death rate, crude
7.46
Mean number of children ever born to women aged 40-49: Q1 (lowest)
3.4
Mean number of children ever born to women aged 40-49: Q2
3.2
Mean number of children ever born to women aged 40-49: Q3
2.8
Mean number of children ever born to women aged 40-49: Q4
2.4
Mean number of children ever born to women aged 40-49: Q5 (highest)
2.2
Current use of contraception (modern method) (% of married women): Q1 (lowest)
10.5 %
Current use of contraception (modern method) (% of married women): Q2
8.9 %
Current use of contraception (modern method) (% of married women): Q3
10.6 %
Current use of contraception (modern method) (% of married women): Q4
9 %
Current use of contraception (modern method) (% of married women): Q5 (highest)
14.2 %
Contraceptive prevalence, modern methods (% of women ages 15-49)
10.6 %
Current use of contraception (any method) (% of married women): Q1 (lowest)
65.5 %
Current use of contraception (any method) (% of married women): Q2
66.8 %
Current use of contraception (any method) (% of married women): Q3
68.7 %
Current use of contraception (any method) (% of married women): Q4
72.2 %
Current use of contraception (any method) (% of married women): Q5 (highest)
73.7 %
Contraceptive prevalence (% of women ages 15-49)
69.3 %
Mortality rate, infant, female (per 1,000 live births)
11.2
Mortality rate, infant (per 1,000 live births)
12.5
Mortality rate, infant, male (per 1,000 live births)
13.7
Infant mortality rate (per 1,000 live births): Q1 (lowest)
28.7
Infant mortality rate (per 1,000 live births): Q2
10.4
Infant mortality rate (per 1,000 live births): Q3
22.9
Infant mortality rate (per 1,000 live births): Q4
17.4
Infant mortality rate (per 1,000 live births): Q5 (highest)
13.2
Life expectancy at birth, female (years)
80.56 years
Life expectancy at birth, total (years)
78.01 years
Life expectancy at birth, male (years)
75.59 years
Fertility rate, total (births per woman)
1.79
Total fertility rate (TFR) (births per woman): Q1 (lowest)
1.9
Total fertility rate (TFR) (births per woman): Q2
1.7
Total fertility rate (TFR) (births per woman): Q3
1.8
Total fertility rate (TFR) (births per woman): Q4
1.5
Total fertility rate (TFR) (births per woman): Q5 (highest)
1.2
Survival to age 65, female (% of cohort)
90.83 %
Survival to age 65, male (% of cohort)
84.79 %
Wanted fertility rate (births per woman)
1.4
Total wanted fertility rate (births per woman): Q1 (lowest)
1.5
Total wanted fertility rate (births per woman): Q2
1.4
Total wanted fertility rate (births per woman): Q3
1.5
Total wanted fertility rate (births per woman): Q4
1.4
Total wanted fertility rate (births per woman): Q5 (highest)
1.1
Female headed households (% of households with a female head)
15.6 %
Women who were first married by age 18 (% of women ages 20-24)
9.6 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q1 (lowest)
1.6 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q2
4.8 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q3
4.5 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q4
1.2 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q5 (highest)
1.6 %
Teenage mothers (% of women ages 15-19 who have had children or are currently pregnant)
2.8 %
Female population 00-04
95000 Persons
Population ages 0-4, female (% of female population)
6.12 %
Male population 00-04
102000 Persons
Population ages 0-4, male (% of male population)
6.69 %
Female population 05-09
74000 Persons
Population ages 5-9, female (% of female population)
5.11 %
Male population 05-09
80000 Persons
Population ages 5-9, male (% of male population)
5.62 %
Female population 10-14
88000 Persons
Population ages 10-14, female (% of female population)
6.46 %
Male population 10-14
95000 Persons
Population ages 10-14, male (% of male population)
7.1 %
Female population 15-19
120000 Persons
Population ages 15-19, female (% of female population)
8.61 %
Male population 15-19
126000 Persons
Population ages 15-19, male (% of male population)
9.2 %
Female population 20-24
131000 Persons
Population ages 20-24, female (% of female population)
9.01 %
Male population 20-24
139000 Persons
Population ages 20-24, male (% of male population)
9.78 %
Female population 25-29
114000 Persons
Population ages 25-29, female (% of female population)
7.56 %
Male population 25-29
125000 Persons
Population ages 25-29, male (% of male population)
8.38 %
Female population 30-34
92000 Persons
Population ages 30-34, female (% of female population)
6.17 %
Male population 30-34
89000 Persons
Population ages 30-34, male (% of male population)
5.87 %
Female population 35-39
84000 Persons
Population ages 35-39, female (% of female population)
5.79 %
Male population 35-39
69000 Persons
Population ages 35-39, male (% of male population)
4.84 %
Female population 40-44
90000 Persons
Population ages 40-44, female (% of female population)
6.3 %
Male population 40-44
77000 Persons
Population ages 40-44, male (% of male population)
5.62 %
Female population 45-49
95000 Persons
Population ages 45-49, female (% of female population)
6.68 %
Male population 45-49
86000 Persons
Population ages 45-49, male (% of male population)
6.19 %
Female population 50-54
104000 Persons
Population ages 50-54, female (% of female population)
7.2 %
Male population 50-54
97000 Persons
Population ages 50-54, male (% of male population)
6.94 %
Female population 55-59
99000 Persons
Population ages 55-59, female (% of female population)
6.62 %
Male population 55-59
96000 Persons
Population ages 55-59, male (% of male population)
6.6 %
Female population 60-64
82000 Persons
Population ages 50-64, female (% of female population)
5.38 %
Male population 60-64
79000 Persons
Population ages 50-64, male (% of male population)
5.36 %
Female population 65-69
61000 Persons
Population ages 65-69, female (% of female population)
4.06 %
Male population 65-69
60000 Persons
Population ages 65-69, male (% of male population)
4.1 %
Population ages 65 and above (% of total)
12.4 %
Female population 70-74
49000 Persons
Population ages 70-74, female (% of female population)
3.34 %
Male population 70-74
48000 Persons
Population ages 70-74, male (% of male population)
3.32 %
Female population 75-79
40000 Persons
Population ages 75-79, female (% of female population)
2.74 %
Male population 75-79
36000 Persons
Population ages 75-79, male (% of male population)
2.47 %
Population ages 80 and above, female
44000 Persons
Population ages 80 and above, female (% of female population)
2.84 %
Male population 80+
30000 Persons
Population ages 80 and above, male (% of male population)
1.92 %
Age population, age 06, female, interpolated
14515 Persons
Age population, age 06, male, interpolated
15655 Persons
Age population, age 07, female, interpolated
14660 Persons
Age population, age 07, male, interpolated
15847 Persons
Age population, age 08, female, interpolated
15078 Persons
Age population, age 08, male, interpolated
16334 Persons
Age population, age 09, female, interpolated
15736 Persons
Age population, age 09, male, interpolated
17070 Persons
Age population, age 10, female, interpolated
16571 Persons
Age population, age 10, male
18007 Persons
Age population, age 11, female, interpolated
17526 Persons
Age population, age 11, male
19094 Persons
Age population, age 12, female, interpolated
18680 Persons
Age population, age 12, male
20311 Persons
Age population, age 13, female, interpolated
20047 Persons
Age population, age 13, male
21623 Persons
Age population, age 14, female, interpolated
21517 Persons
Age population, age 14, male
22971 Persons
Age population, age 15, female, interpolated
22972 Persons
Age population, age 15, male, interpolated
24321 Persons
Age population, age 16, female, interpolated
24435 Persons
Age population, age 16, male, interpolated
25668 Persons
Age population, age 17, female, interpolated
25578 Persons
Age population, age 17, male, interpolated
26771 Persons
Age population, age 18, female, interpolated
26231 Persons
Age population, age 18, male, interpolated
27508 Persons
Age population, age 19, female, interpolated
26502 Persons
Age population, age 19, male, interpolated
27942 Persons
Age population, age 20, female, interpolated
26727 Persons
Age population, age 20, male, interpolated
28288 Persons
Age population, age 21, female, interpolated
26891 Persons
Age population, age 21, male, interpolated
28527 Persons
Age population, age 22, female, interpolated
26703 Persons
Age population, age 22, male, interpolated
28458 Persons
Age population, age 23, female, interpolated
26067 Persons
Age population, age 23, male, interpolated
28009 Persons
Age population, age 24, female, interpolated
25121 Persons
Age population, age 24, male, interpolated
27262 Persons
Age population, age 25, female, interpolated
24118 Persons
Age population, age 25, male, interpolated
26426 Persons
Age dependency ratio (% of working-age population)
44.81 %
Age dependency ratio, old (% of working-age population)
17.95 %
Age dependency ratio, young (% of working-age population)
26.86 %
Population, female (% of total)
50.4 %
Completeness of birth registration, rural
98.4 %
Completeness of birth registration, urban
99 %
Completeness of birth registration
98.6 %
Completeness of death registration with cause-of-death information
53
Unmet need for family planning (for limiting) (% of married women): Q1 (lowest)
11.6 %
Unmet need for family planning (for limiting) (% of married women): Q2
10.4 %
Unmet need for family planning (for limiting) (% of married women): Q3
10.1 %
Unmet need for family planning (for limiting) (% of married women): Q4
8.8 %
Unmet need for family planning (for limiting) (% of married women): Q5 (highest)
5.7 %
Unmet need for family planning (for spacing) (% of married women): Q1 (lowest)
4.3 %
Unmet need for family planning (for spacing) (% of married women): Q2
3.2 %
Unmet need for family planning (for spacing) (% of married women): Q3
3.7 %
Unmet need for family planning (for spacing) (% of married women): Q4
3.5 %
Unmet need for family planning (for spacing) (% of married women): Q5 (highest)
2.9 %
Unmet need for contraception (% of married women ages 15-49)
12.9 %
Unmet need for family planning (total) (% of married women): Q1 (lowest)
15.9 %
Unmet need for family planning (total) (% of married women): Q2
13.6 %
Unmet need for family planning (total) (% of married women): Q3
13.8 %
Unmet need for family planning (total) (% of married women): Q4
12.3 %
Unmet need for family planning (total) (% of married women): Q5 (highest)
8.6 %